1	Iniciar	iniciar	VMN0000	-	-	0-7	316(1)_ANS_clinical_caseMIR	SENT1	-	-
2	pauta	pauta	NCFS000	-	-	8-13	316(1)_ANS_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	14-16	316(1)_ANS_clinical_caseMIR	SENT1	-	-
4	glucocorticoides	glucocorticoide	NCMP000	C0017710	producto#sustancia	17-33	316(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	orales	oral	AQ0CP0	C0442027	calificador	34-40	316(1)_ANS_clinical_caseMIR	SENT1	-	-
6	durante	durante	SPS00	C1444752#C0347984	atributo	41-48	316(1)_ANS_clinical_caseMIR	SENT1	-	-
7	6	6		-	-	49-50	316(1)_ANS_clinical_caseMIR	SENT1	-	-
8	meses	mes	NCMP000	C0439231	calificador	51-56	316(1)_ANS_clinical_caseMIR	SENT1	-	-
9	para	para	SPS00	C0521125	calificador	57-61	316(1)_ANS_clinical_caseMIR	SENT1	-	-
10	el	el	DA0MS0	-	-	62-64	316(1)_ANS_clinical_caseMIR	SENT1	-	-
11	control	control	NCMS000	C2587213	atributo	65-72	316(1)_ANS_clinical_caseMIR	SENT1	-	-
12	de	de	SPS00	C0332285	atributo	73-75	316(1)_ANS_clinical_caseMIR	SENT1	-	-
13	las	el	DA0FP0	-	-	76-79	316(1)_ANS_clinical_caseMIR	SENT1	-	-
14	exacerbaciones	exacerbaci√≥n	NCFP000	-	-	80-94	316(1)_ANS_clinical_caseMIR	SENT1	-	-
15	.	.	Fp	-	-	95-96	316(1)_ANS_clinical_caseMIR	SENT1	-	-

